|
1
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hammond SM: An overview of microRNAs. Adv
Drug Deliv Rev. 87:3–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Soifer HS, Rossi JJ and Saetrom P:
MicroRNAs in disease and potential therapeutic applications. Mol
Ther. 15:2070–2079. 2017. View Article : Google Scholar
|
|
4
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
O'Connell RM, Rao DS, Chaudhuri AA and
Baltimore D: Physiological and pathological roles for microRNAs in
the immune system. Nat Rev Immunol. 10:111–122. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tutar Y: miRNA and cancer; computational
and experimental approaches. Curr Pharm Biotechnol. 15:4292014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhong Z, Hou J, Zhang Q, Zhong W, Li B, Li
C, Liu Z, Yang M and Zhao P: Circulating microRNA expression
profiling and bioinformatics analysis of dysregulated microRNAs of
patients with coronary artery disease. Medicine (Baltimore).
97:e114282018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang S, Zhang R, Wu F and Li X:
MicroRNA-208a regulates H9c2 cells simulated ischemia-reperfusion
myocardial injury via targeting CHD9 through Notch/NF-kappa B
signal pathways. Int Heart J. 59:580–588. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Price NL, Ramírez CM and
Fernández-Hernando C: Relevance of microRNA in metabolic diseases.
Crit Rev Clin Lab Sci. 51:305–320. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qiu L, Tan EK and Zeng L: microRNAs and
neurodegenerative diseases. Adv Exp Med Biol. 888:85–105. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rossi M, Tagliaferri P and Tassone P:
MicroRNAs in multiple myeloma and related bone disease. Ann Transl
Med. 3:3342015.PubMed/NCBI
|
|
12
|
Majidinia M, Sadeghpour A and Yousefi B:
The roles of signaling pathways in bone repair and regeneration. J
Cell Physiol. 233:2937–2948. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu C, Zhang T, Ren B, Deng Z, Cai L, Lei J
and Ping A: Effect of vacuum-assisted closure combined with open
bone grafting to promote rabbit bone graft vascularization. Med Sci
Monit. 21:1200–1206. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lian JB, Stein GS, van Wijnen AJ, Stein
JL, Hassan MQ, Gaur T and Zhang Y: MicroRNA control of bone
formation and homeostasis. Nat Rev Endocrinol. 8:212–227. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Valenti MT, Dalle Carbonare L and Mottes
M: Role of microRNAs in progenitor cell commitment and osteogenic
differentiation in health and disease (Review). Int J Mol Med.
41:2441–2449. 2018.PubMed/NCBI
|
|
16
|
Tang J, Zhang Z, Jin X and Shi H: miR-383
negatively regulates osteoblastic differentiation of bone marrow
mesenchymal stem cells in rats by targeting Satb2. Bone.
114:137–143. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Arfat Y, Basra MAR, Shahzad M, Majeed K,
Mahmood N and Munir H: miR-208a-3p suppresses osteoblast
differentiation and inhibits bone formation by targeting ACVR1. Mol
Ther Nucleic Acids. 11:323–336. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang L, Tang Y, Zhu X, Tu T, Sui L, Han
Q, Yu L, Meng S, Zheng L, Valverde P, et al: Overexpression of
MiR-335-5p promotes bone formation and regeneration in mice. J Bone
Miner Res. 32:2466–2475. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang M, Qing Y, Shi Q, Cao Y and Song K:
miR-342-3p elevates osteogenic differentiation of umbilical cord
mesenchymal stem cells via inhibiting Sufu in vitro. Biochem
Biophys Res Commun. 491:571–577. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Bao W, Liu Y, Wang S, Xu S, Li X,
Li Y and Wu S: miR-98-5p contributes to cisplatin resistance in
epithelial ovarian cancer by suppressing miR-152 biogenesis via
targeting Dicer1. Cell Death Dis. 9:4472018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fu Y, Liu X, Chen Q, Liu T, Lu C, Yu J,
Miao Y and Wei J: Downregulated miR-98-5p promotes PDAC
proliferation and metastasis by reversely regulating MAP4K4. J Exp
Clin Cancer Res. 37:1302018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu F, Mo Q, Wan X, Dan J and Hu H:
NEAT1/hsa-mir-98- 5p/MAPK6 axis is involved in non-small-cell lung
cancer development. J Cell Biochem. 120:2836–2846. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang T, Li M, Li Q, Guo Z, Sun X, Zhang
X, Liu Y, Yao W and Xiao P: MicroRNA-98-5p inhibits cell
proliferation and induces cell apoptosis in hepatocellular
carcinoma via targeting IGF2BP1. Oncol Res. 25:1117–1127. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Q, Li X, Wang L, Zhang Y and Chen L:
miR-98-5p acts as a target for Alzheimer's disease by regulating Aβ
production through modulating SNX6 expression. J Mol Neurosci.
60:413–420. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sahu M and Mallick B: Deciphering
synergistic regulatory networks of microRNAs in hESCs and
fibroblasts. Int J Biol Macromol. 113:1279–1286. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Park SM, Shell S, Radjabi AR, Schickel R,
Feig C, Boyerinas B, Dinulescu DM, Lengyel E and Peter ME: Let-7
prevents early cancer progression by suppressing expression of the
embryonic gene HMGA2. Cell Cycle. 6:2585–2590. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kalomoiris S, Cicchetto AC, Lakatos K,
Nolta JA and Fierro FA: Fibroblast growth factor 2 regulates high
mobility group A2 expression in human bone marrow-derived
mesenchymal stem cells. J Cell Biochem. 117:2128–2137. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wei J, Li H, Wang S, Li T, Fan J, Liang X,
Li J, Han Q, Zhu L, Fan L and Zhao RC: let-7 enhances osteogenesis
and bone formation while repressing adipogenesis of human
stromal/mesenchymal stem cells by regulating HMGA2. Stem Cells Dev.
23:1452–1463. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tian Z, Zhou H, Xu Y and Bai J:
MicroRNA-495 inhibits new bone regeneration via targeting high
mobility group AT-Hook 2 (HMGA2). Med Sci Monit. 23:4689–4698.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Matsubara T, Suardita K, Ishii M, Sugiyama
M, Igarashi A, Oda R, Nishimura M, Saito M, Nakagawa K, Yamanaka K,
et al: Alveolar bone marrow as a cell source for regenerative
medicine: Differences between alveolar and iliac bone marrow
stromal cells. J Bone Miner Res. 20:399–409. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ni P, Xie J, Chen C, Jiang Y, Zhao Z,
Zhang Y, Lu Y and Yu J: Spectrophotometric determination of the
activity of alkaline phosphatase and detection of its inhibitors by
exploiting the pyrophosphate-accelerated oxidase-like activity of
nanoceria. Mikrochim Acta. 186:3202019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kureel J, John AA, Dixit M and Singh D:
MicroRNA-467g inhibits new bone regeneration by targeting
Ihh/Runx-2 signaling. Int J Biochem Cell Biol. 85:35–43. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang Y, Gao Y, Cai L, Li F, Lou Y, Xu N,
Kang Y and Yang H: MicroRNA-221 is involved in the regulation of
osteoporosis through regulates RUNX2 protein expression and
osteoblast differentiation. Am J Transl Res. 9:126–135.
2017.PubMed/NCBI
|
|
35
|
Liu J, Li Y, Luo M, Yuan Z and Liu J:
MicroRNA-214 inhibits the osteogenic differentiation of human
osteoblasts through the direct regulation of baculoviral IAP
repeat-containing 7. Exp Cell Res. 351:157–162. 2017. View Article : Google Scholar : PubMed/NCBI
|
